Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy × Ado-Trastuzumab Emtansine × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Salivary Gland Neoplasms 2 Neoplasm Metastasis 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Patient Preference 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Inflammatory Breast Neoplasms 1 Hemangiosarcoma 1 HER2-positive Metastatic Breast Cancer 1 Colorectal Neoplasms 1 Brain Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1 Adenocarcinoma Of Esophagus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡